Zardaverine

Zardaverine

SCHEMBL29388700

COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 6/20 1.00
PDE4B Q07343 6/20 1.00
PDE4C Q08493 6/20 1.00
PDE4D Q08499 6/20 1.00
PDE3B Q13370 6/20 1.00
PDE3A Q14432 6/20 1.00
LMNA P02545 3/20 1.00
CYP1A2 P05177 3/20 1.00
MAPK1 P28482 3/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
CYP2C9 P11712 2/20 1.00
CYP2C19 P33261 2/20 1.00
TP53 P04637 1/20 1.00
HPGD P15428 1/20 1.00
TSHR P16473 1/20 1.00
BLM P54132 1/20 1.00
PMP22 Q01453 1/20 1.00
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zardaverine SCHEMBL13334 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
Zardaverine SCHEMBL15263214 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10779323 0.95 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10764347 0.88 PDE4A (0.79) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL8479743 0.87 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10758345 0.84 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL21969548 0.83 PDE3A (0.70) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10761953 0.83 PDE4B (0.79) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL8635918 0.82 PDE4D (0.69) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL29892342 0.82 PDE4A (0.69) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3334404-B1 COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A AND SLFN12 BROAD INST INC (US) 2024-09-18 EP claimed
EP-2704560-B1 ORGAN CARE SOLUTION FOR EX-VIVO MACHINE PERFUSION OF DONOR LUNGS TRANSMEDICS INC (US) 2022-04-06 EP claimed
CN-114053280-A Application of phosphodiesterase inhibitor or pharmaceutical composition thereof in preparation of medicine for treating novel coronavirus pneumonia 南方科技大学 2022-02-18 CN claimed
WO-2022027180-A1 APPLICATION OF PHOSPHODIESTERASE INHIBITOR OR PHARMACEUTICAL COMPOSITION THEREOF IN PREPARATION OF DRUG FOR TREATING NOVEL CORONAVIRUS PNEUMONIA 南方科技大学 2022-02-10 WO claimed
CN-119012999-A Improved nasal administration of pharmaceutical formulations 思瑞诺医疗有限公司 2024-11-22 CN disclosed
CN-118871101-A Improved nasal administration of parkinson's disease therapeutic agents 思瑞诺医疗有限公司 2024-10-29 CN disclosed
CN-118715013-A Nasal spray for phosphodiesterase inhibitors 思瑞诺医疗有限公司 2024-09-27 CN disclosed
CN-118159644-A Method for producing enteroendocrine cells, enteroendocrine cells derived from pluripotent stem cells, medium or medium kit, and use thereof 富士胶片株式会社 2024-06-07 CN disclosed
CN-113473993-B Methods and compositions for treating motor neuron diseases 巴伦西亚大学 2024-06-04 CN disclosed
CN-111684058-B Method for inducing differentiation from pluripotent stem cells into intestinal epithelial cells 公立大学法人名古屋市立大学 2023-07-28 CN disclosed
US-20220347170-A1 Method of Reducing Brow Ache LENZ THERAPEUTICS OPERATIONS, INC. 2022-11-03 US disclosed
WO-2022232205-A1 A METHOD OF REDUCING BROW ACHE LENZ THERAPEUTICS, INC. (US) 2022-11-03 WO disclosed
WO-2022148418-A1 PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER 江苏恒瑞医药股份有限公司 2022-07-14 WO disclosed
CN-114699528-A Compositions and methods for PDE3A or SLFN12 expressing cancers 布罗德研究所股份有限公司 2022-07-05 CN disclosed
CN-108366947-B Compositions and methods for PDE3A or SLFN12 expressing cancers 布罗德研究所股份有限公司 2022-03-29 CN disclosed
CN-114053280-A Application of phosphodiesterase inhibitor or pharmaceutical composition thereof in preparation of medicine for treating novel coronavirus pneumonia 南方科技大学 2022-02-18 CN disclosed
CN-114053280-A Application of phosphodiesterase inhibitor or pharmaceutical composition thereof in preparation of medicine for treating novel coronavirus pneumonia 南方科技大学 2022-02-18 CN disclosed
WO-2022027180-A1 APPLICATION OF PHOSPHODIESTERASE INHIBITOR OR PHARMACEUTICAL COMPOSITION THEREOF IN PREPARATION OF DRUG FOR TREATING NOVEL CORONAVIRUS PNEUMONIA 南方科技大学 2022-02-10 WO disclosed